Cresp 40 Injection
Marketer
Dr Reddy's Laboratories Ltd
Salt Composition
Darbepoetin alfa (40mcg)
Overview Cresp 40 Injection
Darbepoetin alfa 40 mcg Injection treats anemia resulting from chronic kidney disease or chemotherapy. Its mechanism involves bone marrow stimulation to increase red blood cell production. This medication requires careful administration due to potential serious adverse reactions; treatment should be overseen by a qualified hematologist. Strict adherence to the physician's instructions is vital. Administration occurs under professional medical supervision. Common side effects encompass abdominal discomfort, hypertension, skin rash, injection site pain, dyspnea, cough, and peripheral edema. Report severe headache, visual disturbances, nausea, vomiting, or convulsions—indicative of dangerously elevated blood pressure—immediately. Regular blood tests, monitoring electrolytes (potassium), hemoglobin, and blood cell counts, are typically ordered. Discontinue use and seek medical advice if shortness of breath or a skin eruption occurs. Prior to commencing therapy, disclose any history of cardiac disease, hypertension, seizures, or strokes. Pregnant, breastfeeding, or intending to become pregnant or breastfeed individuals should consult their physician regarding safety.
Uses of Cresp 40 Injection
Managing anemia in chronic kidney disease patients | Addressing chemotherapy-induced anemia
Major Benefits of Cresp 40 Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cresp 40 Injection:
- Abdominal pain
- High blood pressure
- Rash
- Injection site pain
- Breathlessness
- Cough
- Peripheral edema
- Procedural hypotension (low blood pressure)
- Convulsion
- Thromboembolism
How to use Cresp 40 Injection:
This medication will be administered by your physician or their qualified associate; self-medication is strongly discouraged.
How Cresp 40 Injection works:
Cresp 40 Injection is an erythropoietin-based medication that boosts red blood cell production. It acts by prompting increased red blood cell synthesis within the bone marrow, the blood cell-generating tissue found inside bones.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Cresp 40 Injection presents unknown safety implications. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Cresp 40 Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible adverse effects prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Administering Cresp 40 Injection while breastfeeding carries a likely risk. Available human data indicates potential transfer to breast milk, posing a possible threat to the infant.
DrivingSAFE
Driving ability is typically unaffected by Cresp 40 Injection.
KidneySAFE IF PRESCRIBED
Cresp 40 Injection poses no safety concerns for individuals with renal impairment; no alteration of the Cresp 40 Injection dosage is necessary.
LiverCAUTION
For individuals with hepatic impairment, Cresp 40 Injection requires careful administration. Dosage modification of Cresp 40 Injection might be necessary. Physician consultation is advised.
What if you forget to take Cresp 40 Injection :
Should you forget a Cresp 40 Injection, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Cresp 40 Injection
| Label | Value |
|---|---|
| Chemical Type | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Actions | Erythropoietin-stimulating drug |




